J, W., R, Z., X, M., X, Z., M, Z., & Y, X. (2026). Feasibility of post-induction consolidation with BCMA CAR-T cell therapy in newly diagnosed multiple myeloma not proceeding to ASCT: A preliminary case series. Cell transplantation, 35, 9636897261449972. https://doi.org/10.1177/09636897261449972
Chicago Style (17th ed.) CitationJ, Wu, Zheng R, Ming X, Zhu X, Zhou M, and Xiao Y. "Feasibility of Post-induction Consolidation with BCMA CAR-T Cell Therapy in Newly Diagnosed Multiple Myeloma Not Proceeding to ASCT: A Preliminary Case Series." Cell Transplantation 35 (2026): 9636897261449972. https://doi.org/10.1177/09636897261449972.
MLA (9th ed.) CitationJ, Wu, et al. "Feasibility of Post-induction Consolidation with BCMA CAR-T Cell Therapy in Newly Diagnosed Multiple Myeloma Not Proceeding to ASCT: A Preliminary Case Series." Cell Transplantation, vol. 35, 2026, p. 9636897261449972, https://doi.org/10.1177/09636897261449972.
